Diversified Enterprises’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$992K Buy
2,355
+513
+28% +$204K 0.05% 174
2026
Q2
$667K Buy
1,842
+12
+0.7% +$4.11K 0.03% 208
2026
Q1
$644K Sell
1,830
-20
-1% -$7.13K 0.04% 204
2025
Q4
$606K Buy
1,850
+1,068
+137% +$339K 0.04% 188
2025
Q3
$221K Sell
782
-31
-4% -$8.99K 0.01% 295
2025
Q2
$227K Sell
813
-529
-39% -$150K 0.02% 286
2025
Q1
$418K Buy
1,342
+335
+33% +$98.9K 0.04% 177
2024
Q4
$263K Buy
1,007
+111
+12% +$32.9K 0.03% 204
2024
Q3
$289K Buy
+896
New +$293K 0.03% 180

Other funds holding AMGN

Diversified Enterprises's AMGN Position: Q3 2026 in Review

Diversified Enterprises increased its Amgen (AMGN) stake by 28% in Q3 2026, buying an estimated $204K and bringing the position to 2,355 shares worth $992K. The position accounts for 0.05% of the portfolio, ranked #174.

Diversified Enterprises first reported a position in AMGN in Q3 2024 and has held it in 9 quarters since. 1,494 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Diversified Enterprises held 2,355 shares of Amgen worth $992K as of Q3 2026.
  • Diversified Enterprises bought 513 Amgen shares in Q3 2026, an estimated $204K.
  • Amgen made up 0.05% of Diversified Enterprises's portfolio in Q3 2026, its #174 holding.
  • Diversified Enterprises first reported a position in Amgen in Q3 2024 and has held it in 9 quarters since.
  • 1,494 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.